Short description
Convergence Pharmaceuticals is a biotechnology company focused on the development of novel analgesics for the treatment of chronic pain.
Description
Convergence Pharmaceuticals is an independent biotechnology company focused on the development of novel analgesics with potentially commercially attractive efficacy, responder-rate and side effect profiles. The Company was formed in October 2010 following the acquisition of certain neuroscience clinical assets from GlaxoSmithKline (“GSKâ€). Convergence Pharmaceuticals has a pipeline of differentiated clinical-stage compounds targeting the points of convergence in chronic pain signaling through modulation of specific ion-channels.
Last funding
Nopepepe
Sign in for full access
Total funding
$$3123123
Sign in for full access
Location
Cambridge, Cambridgeshire, United Kingdom, Europe
Founded on
January 1, 2010
Closed on
February 12, 2015
Exited on
January 11, 2015
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$1230 - 4560
Sign in for full access
Investors
Nopepepe, Noaccessforu, Noaccessforu
Sign in for full access
Founders
Brenda Reynolds, Clive Dix